Colony Group LLC Amgen Inc Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Colony Group LLC holds 27,144 shares of AMGN stock, worth $7.15 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

27,144

Previous 26,389 2.86%

Holding current value

$7.15 Million

Previous $5.86 Million 24.51%

% of portfolio

0.11%

Previous 0.08%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $165,080 - $204,952	755 Added 2.86%	27,144 $7.3 Million
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $138,846 - $164,183	648 Added 2.52%	26,389 $5.86 Million
Q1 2023 May 16, 2023	SELL	$225.79 - $275.2 $411,163 - $501,139	-1,821 Reduced 6.61%	25,741 $6.22 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $515,088 - $654,481	-2,249 Reduced 7.54%	27,562 $7.24 Million
Q3 2022 Nov 15, 2022	BUY	$224.46 - $253.15 $119,188 - $134,422	531 Added 1.81%	29,811 $6.72 Million
Q2 2022 Aug 16, 2022	SELL	$230.71 - $256.74 $113,047 - $125,802	-490 Reduced 1.65%	29,280 $7.12 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $593,563 - $656,636	2,707 Added 10.0%	29,770 $7.2 Million
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $174,815 - $200,060	-879 Reduced 3.15%	27,063 $6.09 Million
Q3 2021 Nov 17, 2021	SELL	$212.27 - $248.7 $3.45 Million - $4.05 Million	-16,265 Reduced 36.79%	27,942 $5.94 Million
Q2 2021 Aug 18, 2021	SELL	$233.58 - $259.14 $4.2 Million - $4.66 Million	-18,000 Reduced 28.94%	44,207 $10.8 Million
Q1 2021 May 21, 2021	SELL	$221.91 - $258.6 $15.6 Million - $18.1 Million	-70,178 Reduced 53.01%	62,207 $15.5 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $1.11 Million - $1.32 Million	-5,124 Reduced 3.73%	132,385 $30.4 Million
Q3 2020 Nov 17, 2020	BUY	$234.65 - $260.95 $993,977 - $1.11 Million	4,236 Added 3.18%	137,509 $34.9 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $919,816 - $1.13 Million	4,650 Added 3.62%	133,273 $31.4 Million
Q1 2020 May 18, 2020	SELL	$182.24 - $241.7 $556,196 - $737,668	-3,052 Reduced 2.32%	128,623 $26.1 Million
Q4 2019 Feb 18, 2020	BUY	$189.21 - $243.2 $914,830 - $1.18 Million	4,835 Added 3.81%	131,675 $31.7 Million
Q3 2019 Nov 26, 2019	BUY	$174.11 - $208.62 $102,724 - $123,085	590 Added 0.47%	126,840 $24.5 Million
Q2 2019 Aug 19, 2019	BUY	$166.7 - $195.41 $2.23 Million - $2.62 Million	13,402 Added 11.88%	126,250 $23.3 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $1.42 Million - $1.6 Million	-7,826 Reduced 6.49%	112,848 $21.4 Million
Q4 2018 Feb 15, 2019	SELL	$178.4 - $208.25 $115,603 - $134,946	-648 Reduced 0.53%	120,674 $23.5 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $403,005 - $454,335	-2,175 Reduced 1.76%	121,322 $25.1 Million
Q2 2018 Aug 15, 2018	BUY	$166.05 - $186.51 $3.16 Million - $3.55 Million	19,057 Added 18.25%	123,497 $22.8 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $561,999 - $656,766	3,317 Added 3.28%	104,440 $17.8 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $185,500 - $207,260	1,099 Added 1.1%	101,123 $17.6 Million
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $16.7 Million - $19.1 Million	100,024	100,024 $18.7 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account